The discovery of endothelium-dependent contraction: The legacy of Paul M. Vanhoutte

被引:22
作者
Barton, Matthias [1 ]
机构
[1] Univ Zurich, CH-8057 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Endothelium; Prostanoids; Vasoconstriction; Blood pressure; Endothelin; Nitric oxide; Vasoactive factors; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; CANINE FEMORAL-ARTERY; RELAXING FACTOR; RECEPTOR ANTAGONISTS; CORONARY-ARTERIES; SUPEROXIDE ANION; VASOCONSTRICTOR SUBSTANCE; GENE-EXPRESSION; BLOOD-PRESSURE;
D O I
10.1016/j.phrs.2011.02.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article summarizes the discovery and the development of endothelial biology with a special focus on the role of endothelium-dependent vasoconstriction. The physician-scientist Paul Michel Vanhoutte contributed many of the initial observations that helped to understand and form the main concepts of modern vascular biology involving endothelial regulation. His laboratory was the first to report endothelial cell-derived vasoconstriction in 1981, followed by the characterization of an endothelium-derived constricting factor published by Hickey et al. in 1985, which was later identified as the endothelin peptide by Yanagisawa et al. in 1988. The identification of the receptor subtypes of this endothelial vasocontrictor two years later, which were named ETA and ETB receptors according to suggestions put forward by Vanhoutte, ultimately resulted in the development of the only new class of drugs that is entirely based on endothelial cell research. More than a quarter century after Vanhoutte's initial description of endothelial vasoconstriction, this first drug class specifically targeting an endothelial vasoconstrictor, the endothelin receptor antagonists, has been firmly established in cardiovascular medicine for the treatment of pulmonary hypertension. This novel therapeutic principle had its beginnings in Vanhoutte's discovery made 30 years ago. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 112 条
  • [11] HORMONE AND NEUROTRANSMITER RECEPTORS IN AN ESTABLISHED VASCULAR ENDOTHELIAL CELL LINE
    BUONASSISI, V
    VENTER, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (05) : 1612 - 1616
  • [12] EDHF:: bringing the concepts together
    Busse, R
    Edwards, G
    Félétou, M
    Fleming, I
    Vanhoutte, PM
    Weston, AH
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) : 374 - 380
  • [13] Epoxyeicosatrienoic acids and endothelium-dependent responses
    Campbell, William B.
    Fleming, Ingrid
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 459 (06): : 881 - 895
  • [14] ACETYLCHOLINE AND BRADYKININ RELAX INTRA-PULMONARY ARTERIES BY ACTING ON ENDOTHELIAL-CELLS - ROLE IN LUNG VASCULAR DISEASES
    CHAND, N
    ALTURA, BM
    [J]. SCIENCE, 1981, 213 (4514) : 1376 - 1379
  • [15] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761
  • [16] Between Confidentiality and Scientific Exchange: The Place of Publication in Drug Discovery and Pharmaceutical Research
    Clozel, Martine
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (67)
  • [17] COHEN RA, 1983, AM J PHYSIOL, V245, P1077
  • [18] Cryer A, 1983, SCALE DIVERSITY INTE
  • [19] Davenport Anthony P., 2002, Trends in Pharmacological Sciences, V23, P155, DOI 10.1016/S0165-6147(00)01975-1
  • [20] ROLE OF THE INTIMA IN CHOLINERGIC AND PURINERGIC RELAXATION OF ISOLATED CANINE FEMORAL ARTERIES
    DEMEY, JG
    VANHOUTTE, PM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1981, 316 (JUL): : 347 - 355